Profound Medical Management
Management criteria checks 4/4
Profound Medical's CEO is Arun Menawat, appointed in Aug 2016, has a tenure of 8.08 years. total yearly compensation is $889.95K, comprised of 41.6% salary and 58.4% bonuses, including company stock and options. directly owns 2.22% of the company’s shares, worth $4.31M. The average tenure of the management team and the board of directors is 2 years and 5 years respectively.
Key information
Arun Menawat
Chief executive officer
US$889.9k
Total compensation
CEO salary percentage | 41.6% |
CEO tenure | 8.1yrs |
CEO ownership | 2.2% |
Management average tenure | 2yrs |
Board average tenure | 5yrs |
Recent management updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$28m |
Mar 31 2024 | n/a | n/a | -US$28m |
Dec 31 2023 | US$890k | US$370k | -US$29m |
Sep 30 2023 | n/a | n/a | -US$29m |
Jun 30 2023 | n/a | n/a | -US$29m |
Mar 31 2023 | n/a | n/a | -US$27m |
Dec 31 2022 | US$916k | US$344k | -US$29m |
Sep 30 2022 | n/a | n/a | -US$29m |
Jun 30 2022 | n/a | n/a | -US$30m |
Mar 31 2022 | n/a | n/a | -US$31m |
Dec 31 2021 | US$4m | US$481k | -US$31m |
Sep 30 2021 | n/a | n/a | -US$28m |
Jun 30 2021 | n/a | n/a | -US$28m |
Mar 31 2021 | n/a | n/a | -US$26m |
Dec 31 2020 | US$2m | US$1m | -US$22m |
Sep 30 2020 | n/a | n/a | -US$18m |
Jun 30 2020 | n/a | n/a | -US$17m |
Mar 31 2020 | n/a | n/a | -US$16m |
Dec 31 2019 | US$2m | US$531k | -US$15m |
Sep 30 2019 | n/a | n/a | -US$15m |
Jun 30 2019 | n/a | n/a | -US$14m |
Mar 31 2019 | n/a | n/a | -US$14m |
Dec 31 2018 | US$672k | US$509k | -US$15m |
Sep 30 2018 | n/a | n/a | -US$16m |
Jun 30 2018 | n/a | n/a | -US$16m |
Mar 31 2018 | n/a | n/a | -US$15m |
Dec 31 2017 | US$264k | US$264k | -US$15m |
Compensation vs Market: Arun's total compensation ($USD889.95K) is below average for companies of similar size in the US market ($USD1.49M).
Compensation vs Earnings: Arun's compensation has been consistent with company performance over the past year.
CEO
Arun Menawat (69 yo)
8.1yrs
Tenure
US$889,948
Compensation
Dr. Arun Swarup Menawat, Ph D., MBA, served as the Chairman at Firefly Neuroscience, Inc. and is its Independent Director. He serves as the Chairman at Profound Medical Corp. Dr. Menawat has been the Chief...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & CEO | 8.1yrs | US$889.95k | 2.22% $ 4.3m | |
Chief Financial Officer | 3.3yrs | US$669.26k | 0.19% $ 371.6k | |
Chief Operating Officer | less than a year | US$396.81k | 0.13% $ 255.9k | |
Senior Vice President for Strategic Alliances | 2yrs | US$226.17k | 0.0039% $ 7.5k | |
Chief Commercial Officer of Global | 2yrs | US$555.98k | 0.053% $ 103.3k | |
Investor Relations | no data | no data | no data | |
VP of International Sales & Marketing | less than a year | no data | no data | |
Assistant Corporate Controller | no data | no data | no data | |
Software Developer | no data | no data | no data |
2.0yrs
Average Tenure
53.5yo
Average Age
Experienced Management: PROF's management team is considered experienced (2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & CEO | 9.3yrs | US$889.95k | 2.22% $ 4.3m | |
Independent Director | 6.3yrs | US$101.96k | 0.071% $ 137.3k | |
Independent Lead Director | 6.3yrs | US$102.91k | 0.28% $ 539.6k | |
Independent Director | 3.5yrs | US$97.91k | 0.025% $ 47.6k | |
Member of Clinical Advisory Board | no data | no data | no data | |
Independent Director | 3.8yrs | US$100.41k | 0.013% $ 25.0k | |
Member of Clinical Advisory Board | no data | no data | no data | |
Member of Clinical Advisory Board | 1.9yrs | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data | |
Member of Clinical Advisory Board | no data | no data | no data |
5.0yrs
Average Tenure
67yo
Average Age
Experienced Board: PROF's board of directors are considered experienced (5 years average tenure).